Ecs-progastrin SA

Switzerland

Back to Profile
1-8 of 8 for Ecs-progastrin SA Sort by
Query
Aggregations
Jurisdiction
        Canada 3
        United States 3
        World 2
Date
2020 3
Before 2020 5
IPC Class
G01N 33/574 - ImmunoassayBiospecific binding assayMaterials therefor for cancer 8
C07K 16/26 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones 5
C07K 16/30 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells 3
A61K 39/00 - Medicinal preparations containing antigens or antibodies 2
A61K 39/395 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum 2
See more
Status
Pending 2
Registered / In Force 6
Found results for  patents

1.

PROGASTRIN AS A BIOMARKER FOR IMMUNOTHERAPY

      
Application Number 16975271
Status Pending
Filing Date 2019-02-27
First Publication Date 2020-12-24
Owner ECS-Progastrin SA (Switzerland)
Inventor Joubert, Dominique

Abstract

Methods for selecting patients responsive to immune checkpoint inhibitors are herein disclosed. Methods of treating cancer patients with an immune checkpoint inhibitor are also provided.

IPC Classes  ?

  • G01N 33/574 - ImmunoassayBiospecific binding assayMaterials therefor for cancer
  • C07K 14/595 - GastrinsCholecystokinins [CCK]

2.

Compositions and methods for detecting prostate cancer

      
Application Number 16498543
Grant Number 11614448
Status In Force
Filing Date 2018-03-30
First Publication Date 2020-06-25
Grant Date 2023-03-28
Owner ECS-Progastrin SA (France)
Inventor Prieur, Alexandre

Abstract

The present invention relates to compositions and methods for the in vitro diagnosis of prostate cancer, wherein said compositions comprise an antibody binding to progastrin and said methods comprise the use of an antibody binding to progastrin.

IPC Classes  ?

  • G01N 33/574 - ImmunoassayBiospecific binding assayMaterials therefor for cancer
  • C07K 16/26 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones
  • C07K 16/30 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
  • A61P 35/00 - Antineoplastic agents
  • A61K 39/395 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • C07K 16/22 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors
  • C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies

3.

Compositions and methods for detecting lung cancer

      
Application Number 16498534
Grant Number 11913958
Status In Force
Filing Date 2018-03-30
First Publication Date 2020-04-02
Grant Date 2024-02-27
Owner ECS-Progastrin SA (Switzerland)
Inventor Prieur, Alexandre

Abstract

The present invention relates to methods for the in vitro diagnosis of lung cancer in a subject, comprising the detection of progastrin using at least one progastrin-binding antibody. According to the method of the invention, the subject is diagnosed with a lung cancer when progastrin is detected in the sample.

IPC Classes  ?

  • G01N 33/574 - ImmunoassayBiospecific binding assayMaterials therefor for cancer
  • C07K 16/26 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones
  • C07K 16/22 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors
  • A61P 35/00 - Antineoplastic agents
  • A61K 39/395 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • C07K 16/30 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
  • C07K 16/32 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products from oncogenes

4.

PROGASTRIN AS A BIOMARKER FOR IMMUNOTHERAPY

      
Document Number 03092414
Status Pending
Filing Date 2019-02-27
Open to Public Date 2019-09-06
Owner ECS-PROGASTRIN SA (Switzerland)
Inventor Joubert, Dominique

Abstract

Methods for selecting patients responsive to immune checkpoint inhibitors are herein disclosed. Methods of treating cancer patients with an immune checkpoint inhibitor are also provided.

IPC Classes  ?

  • C07K 16/26 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones
  • G01N 33/574 - ImmunoassayBiospecific binding assayMaterials therefor for cancer

5.

PROGASTRIN AS A BIOMARKER FOR IMMUNOTHERAPY

      
Application Number EP2019054878
Publication Number 2019/166499
Status In Force
Filing Date 2019-02-27
Publication Date 2019-09-06
Owner ECS-PROGASTRIN SA (Switzerland)
Inventor Joubert, Dominique

Abstract

Methods for selecting patients responsive to immune checkpoint inhibitors are herein disclosed. Methods of treating cancer patients with an immune checkpoint inhibitor are also provided.

IPC Classes  ?

  • G01N 33/574 - ImmunoassayBiospecific binding assayMaterials therefor for cancer
  • C07K 16/26 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones

6.

COMBINATION OF PROGASTRIN DETECTION WITH OTHER CANCER BIOMARKERS IN CANCER DIAGNOSIS

      
Application Number EP2019052005
Publication Number 2019/145537
Status In Force
Filing Date 2019-01-28
Publication Date 2019-08-01
Owner ECS-PROGASTRIN SA (Switzerland)
Inventor Prieur, Alexandre

Abstract

vitrovitro diagnosis of a specific cancer, wherein said methods comprise the use of an antibody binding to progastrin and of a biomarker specific for said cancer.

IPC Classes  ?

  • G01N 33/574 - ImmunoassayBiospecific binding assayMaterials therefor for cancer
  • G01N 33/74 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving hormones

7.

COMPOSITIONS AND METHODS FOR DETECTING PROSTATE CANCER

      
Document Number 03058263
Status In Force
Filing Date 2018-03-30
Open to Public Date 2018-10-04
Grant Date 2023-08-01
Owner ECS-PROGASTRIN SA (Switzerland)
Inventor Prieur, Alexandre

Abstract

The present invention relates to compositions and methods for the in vitro diagnosis of prostate cancer, wherein said compositions comprise an antibody binding to progastrin and said methods comprise the use of an antibody binding to progastrin.

IPC Classes  ?

  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
  • C07K 16/30 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
  • G01N 33/574 - ImmunoassayBiospecific binding assayMaterials therefor for cancer

8.

COMPOSITIONS AND METHODS FOR DETECTING LUNG CANCER

      
Document Number 03058270
Status In Force
Filing Date 2018-03-30
Open to Public Date 2018-10-04
Grant Date 2023-07-18
Owner ECS-PROGASTRIN SA (Switzerland)
Inventor Prieur, Alexandre

Abstract

The present invention relates to compositions and methods for the in vitro diagnosis of lung cancer, wherein said compositions comprise an antibody binding to progastrin and said methods comprise the use of an antibody binding to progastrin.

IPC Classes  ?

  • C07K 16/26 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones
  • G01N 33/574 - ImmunoassayBiospecific binding assayMaterials therefor for cancer
  • G01N 33/74 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving hormones